Injectable treatment to reduce belly fat in adults
Treatments studied
Part of Skin clinical trials.
This study tests a new injectable medication (CBL-514) designed to reduce stubborn fat under the skin in the abdominal area. Researchers will evaluate how well it works, its safety, and how patients tolerate it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- BMI between 18.5 and 30, and weigh at least 50 kg (110 lbs)
- Have moderate or more abdominal subcutaneous fat (confirmed by both doctor assessment and your own rating)
- Maintain a stable lifestyle during the study
- Completed a previous Stage 1 study or eligible to participate in it
- Willing to use contraception if of childbearing age, through 90 days after final treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether CBL-514, an injection given under the skin, can safely reduce stubborn belly fat in people with normal to slightly elevated weight. Researchers will measure changes in abdominal fat using imaging and patient assessments.
This study tests whether CBL-514, an injectable medication, can safely reduce unwanted fat deposits under the skin in the abdomen. If it works, it could offer people a non-surgical option to improve the appearance of belly fat they're unhappy with.
This trial tests an injection called CBL-514 to reduce stubborn belly fat in people who are at a healthy weight but have moderate to severe abdominal fat. It may be an option if you've kept a stable lifestyle and are looking for a non-surgical approach.
This study checks if the effects of a previous fat-reducing treatment (CBL-514) last over time and if it remains safe. It's for people who already completed an earlier study with this treatment.
This trial tests a new injection called MI226 to reduce belly fat. It is for people with noticeable belly fat who want to see if this treatment can help slim that area.
This study tests an investigational weight-loss injection, IN-B00009, for adults with obesity or overweight who don't have diabetes. It aims to see if the drug is safe and effective for helping you lose weight, along with diet and exercise.
Hear when a new Subcutaneous Fat trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.